Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01707667 · ClinicalTrials.gov registry record · Phase 4
Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity
A Phase 4 study, sponsored by Shire.
- Completed
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT01707667 is a Phase 4 study that has completed, run by Shire. The registered enrollment target is 13 participants.
The verdict
NCT01707667, a Phase 4 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
To evaluate the different effects of prucalopride and PEG 3350 + electrolytes on colon motor activity in subjects that are chronically constipated.
Interventions
- DRUG PEG 3350
- DRUG prucalopride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-02-27 |
| Est. Completion | 2013-11-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01707667
The ClinicalTrials.gov registry entry for NCT01707667 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PEG 3350 is the first listed.
NCT01707667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01707667 about?
NCT01707667 is a clinical study titled "Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity". To evaluate the different effects of prucalopride and PEG 3350 + electrolytes on colon motor activity in subjects that are chronically constipated.
What is the current status of trial NCT01707667?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2013-02-27. Estimated completion is 2013-11-27.
What interventions are being tested in trial NCT01707667?
The interventions under investigation include: PEG 3350 (DRUG), prucalopride (DRUG).
Who is sponsoring clinical trial NCT01707667?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.